Patents by Inventor Eduardo Forleo Neto

Eduardo Forleo Neto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for treating or preventing SARS-CoV-2 infections and COVID-19 with anti-SARS-CoV-2 spike glycoprotein antibodies
    Patent number: 11999777
    Abstract: The present invention provides methods for preventing and treating SARS-CoV-2 infections, COVID-19, or symptoms thereof. The methods of the invention feature the administration of one or more antigen-binding molecules (e.g., antibodies) that bind a surface protein of SARS-CoV-2 (e.g., spike protein).
    Type: Grant
    Filed: June 2, 2021
    Date of Patent: June 4, 2024
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Samit Ganguly, Jennifer Hamilton, Gary Herman, Andrea Hooper, Flonza Isa, Meagan O'Brien, Sumathi Sivapalasingam, Kenneth Turner, Eduardo Forleo Neto
  • Methods for Treating or Preventing SARS-CoV-2 Infections and COVID-19 with Anti-SARS-CoV-2 Spike Glycoprotein Antibodies
    Publication number: 20210395345
    Abstract: The present invention provides methods for preventing and treating SARS-CoV-2 infections, COVID-19, or symptoms thereof. The methods of the invention feature the administration of one or more antigen-binding molecules (e.g., antibodies) that bind a surface protein of SARS-CoV-2 (e.g., spike protein).
    Type: Application
    Filed: June 2, 2021
    Publication date: December 23, 2021
    Inventors: Samit Ganguly, Jennifer Hamilton, Gary Herman, Andrea Hooper, Flonza Isa, Meagan O'Brien, Sumathi Sivapalasingam, Kenneth Turner, Eduardo Forleo Neto
  • TREATMENT OF FIBRODYSPLASIA OSSIFICANS PROGRESSIVA
    Publication number: 20210253685
    Abstract: Methods for treating fibrodysplasia ossificans progressiva (FOP) in human subjects are provided. Such methods involve administering to a subject having FOP a therapeutically effective amount of an Activin A antagonist, such as an antibody against Activin A.
    Type: Application
    Filed: January 8, 2021
    Publication date: August 19, 2021
    Inventors: Aristides Economides, Eduardo Forleo Neto, Dinko Gonzalez Trotter, Gary Herman, Andrew Rankin, Scott Mellis